🇺🇸 FDA

Company profile · Sponsor

Sinobioway

Sinobioway Cell Therapy Co.,

CB882D8 · NMPA pharma CN
Pipeline
1
Drugs
0
Patents
0

Quick answer

Sinobioway (CB882D8) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CB882D8
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (1)

Search pipeline →

  1. The Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T)

    Sinobioway

    Lymphoma

    phase 1 mab active

    1 trial

Frequently asked questions

What is Sinobioway?

Sinobioway (CB882D8) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Sinobioway sponsor?

We track 1 ClinicalTrials.gov-linked program for Sinobioway, including The Chimeric Antigen Receptor T Cell Immunotherapy (CAR-T). Open each program for phase, modality, NCT IDs, and indication details.

Where does Sinobioway company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.